Amyloid-beta and tau protein beyond Alzheimer’s diseaseMorteza Abyadeh, Mehdi Mirzaei, Vivek Gupta et al.|Neural Regeneration Research|2023Cited by 98
Expansion of chronic lesions is linked to disease progression in relapsing–remitting multiple sclerosis patientsSamuel Klistorner, Alexander Klistorner, Michael Barnett et al.|Multiple Sclerosis Journal|2020Cited by 53
Mitochondrial dysfunction in Alzheimer’s disease - a proteomics perspectiveMorteza Abyadeh, Mehdi Mirzaei, Nitin Chitranshi et al.|Expert Review of Proteomics|2021Cited by 49
Fingolimod effects on the brain are mediated through biochemical modulation of bioenergetics, autophagy, and neuroinflammatory networksMehdi Mirzaei, Stuart L. Graham, Morteza Abyadeh et al.|PROTEOMICS|2022Cited by 20
Dysregulation of the Kynurenine Pathway in Relapsing Remitting Multiple Sclerosis and Its Correlations With Progressive NeurodegenerationAnanda Staats Pires, Benjamin Heng, Shivani Krishnamurthy et al.|Neurology Neuroimmunology & Neuroinflammation|2025Cited by 16